Skip to main content
TipRanks
Go Ultimate75% OFF

Newron Pharmaceuticals SpA (NP5) Q4 2022 Earnings Report

3 Followers

DE:NP5 Q4 2022 EPS Results

Actual EPS
-EUR 0.52
Consensus EPS
―
Beat/Miss
―
One Year Ago EPS
-EUR 0.38

DE:NP5 Q4 2022 Revenue Results

Actual Revenue
EUR 3.44M
Expected Revenue
―
Beat/Miss
―
YoY Revenue Growth
-3.25%

Earnings Announcement Details

Quarter
Q4 2022
Date
03/14/2023
Time
Before Open
Conference Call
Tuesday, March 14, 2023
DE:NP5 Upcoming Earnings

Newron Pharmaceuticals SpA's next earnings date is estimated for March 16, 2027, based on past reporting schedules.

Q4 2022 Earnings Call Audio

No earnings call audio is available for this earnings event.

Q4 2022 Earnings Slide Deck

No slide deck is available for this earnings event.

Q4 2022 Earnings Call Summary

No earnings call summary is available for this earnings event.

DE:NP5 Earnings History

DE:NP5 earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Mar 16, 20272026 (Q4)-0.77--0.66――
Sep 22, 20262026 (Q2)-0.19-0.800―
Mar 24, 20262025 (Q4)-0.08-0.661.2-154.95% (-1.86)
Sep 16, 20252025 (Q2)-0.410.00-0.51100.00% (+0.51)
Apr 01, 20252024 (Q4)―1.29-0.54341.16% (+1.83)
Sep 19, 20242024 (Q2)―-0.51-0.39-30.77% (-0.12)
Mar 19, 20242023 (Q4)―-0.54-0.52-2.47% (-0.01)
Aug 04, 20232023 (Q2)―-0.39-0.4818.75% (+0.09)
Mar 14, 20232022 (Q4)―-0.52-0.38-39.26% (-0.15)
Sep 15, 20222022 (Q2)―-0.48-0.515.88% (+0.03)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed